# Anti‐IL‐5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/anti-il-5-recombinant-humanized-monoclonal-antibody-mepolizumab-for-the/

## Facts

| Field | Value |
| --- | --- |
| Author Names | J Oldhoff,Ulf Darsow,Thomas Werfel,K. Katzer,A. Wulf,J. Laifaoui,DirkJan Hijnen,Sabine G. Plötz,Edward F. Knol,Alexander Kapp,C. A. F. M. Bruijnzeel‐Koomen,Johannes Ring,Marjolein de Bruin‐Weller |
| Citations | 338 |
| DOI | 10.1111/j.1398-9995.2005.00791.x |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2025830579 |
| PMID | 15813818 |
| Type | article |
| Year | 2005 |

## Paper authors

- [Thomas Werfel](https://scholariq.org/researchers/thomas-werfel/)
- [Marjolein de Bruin‐Weller](https://scholariq.org/researchers/marjolein-de-bruin-weller/)

## Paper journal

- [Allergy](https://scholariq.org/journals/allergy/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.